Moreover, the BRCA1 loss mutation, like oncogene activation (RAS, NF-κB, TGF-β), in cancer cells will drive the initiation of metabolic symbiosis phenotype between tumor cells and fibroblasts in both primary and metastatic cancers (226). This evidence concerns the gene TGFB1 and neoplasm.